Investigators from NCCN Member Organizations meet the criteria to apply for the research funding.

The National Comprehensive Cancers Network provides been awarded a extensive analysis grant from Allos Therapeutics, Inc. To aid clinical studies of pralatrexate , Allos Therapeutics, Inc.) in the treatment of select hematologic malignancies and solid tumors. Pralatrexate was lately accepted by the FDA to treat patients with refractory or relapsed peripheral T-cell lymphoma, a type of non-Hodgkin’s lymphoma that is relatively uncommon, but aggressive particularly. Clinical trials supported by this grant will focus on evaluating innovative single agent and combination research of pralatrexate in Burkitt’s lymphoma, multiple myeloma, particular indolent lymphomas, ovarian tumor, neck and head cancer, prostate malignancy, gastroesophageal cancer, and colorectal tumor.The November 2007 problem of Mayo Clinic Women's HealthSource presents a fresh look at this ancient practice and how it is being incorporated into Western medication. Regarding to traditional Chinese medicine, vital energy flows along particular pathways within the physical body, known as meridians. The belief is definitely that one way to unblock energy circulation – – and promote the body's capability to heal itself – – is to insert hair-thin needles to different depths in strategic points along this meridian.